12.9 C
New York
Tuesday, April 23, 2024

Bernstein Downgrades Johnson & Johnson To Market Perform, Shares Drop

Courtesy of Benzinga.

Related JNJ
Achillion Pharmaceuticals, Inc. Less Attractive Amid Johnson & Johnson/Alios BioPharma Deal
#PreMarket Primer: Thursday, September 25: US Airstrikes Do Little To Stem ISIS Advances
U.S., U.K. ISIS Response Differ Widely (Fox Business)

Analysts at Bernstein downgraded Johnson & Johnson (NYSE: JNJ) from undefined to Market Perform.

Johnson & Johnson shares have gained 22.11% over the past 52 weeks, while the S&P 500 index has surged 16.44% in the same period.

Johnson & Johnson’s shares fell 0.92% to $105.61 in pre-market trading.

Latest Ratings for JNJ

Date Firm Action From To
Oct 2014 Bernstein Downgrades Market Perform
Aug 2014 Jefferies Maintains Hold
Jul 2014 Citigroup Maintains Buy

View More Analyst Ratings for JNJ
View the Latest Analyst Ratings

Posted-In: BernsteinDowngrades Analyst Ratings

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

157,332FansLike
396,312FollowersFollow
2,290SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x